Reversal effects of Raloxifene on paclitaxel resistance in 2 MDR breast cancer cells.

about

Reversal effects of Raloxifene on paclitaxel resistance in 2 MDR breast cancer cells.

Item

http://www.wikidata.org/entity/Q36843815

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Reversal effects of Raloxifene on paclitaxel resistance in 2 MDR breast cancer cells.

@en

type

Item

label

Reversal effects of Raloxifene on paclitaxel resistance in 2 MDR breast cancer cells.

@en

prefLabel

Reversal effects of Raloxifene on paclitaxel resistance in 2 MDR breast cancer cells.

@en

P1476

Reversal effects of Raloxifene on paclitaxel resistance in 2 MDR breast cancer cells.

@en

P2093

Donghai Jiang

http://www.w3.org/2001/XMLSchema#string

Jingyu Lei

http://www.w3.org/2001/XMLSchema#string

Liang Xu

http://www.w3.org/2001/XMLSchema#string

Lin Zhou

http://www.w3.org/2001/XMLSchema#string

Shu Wang

http://www.w3.org/2001/XMLSchema#string

Weimin Fan

http://www.w3.org/2001/XMLSchema#string

P2860

Reversal effects of nomegestrol acetate on multidrug resistance in adriamycin-resistant MCF7 breast cancer cell line

Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial

Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines

Tamoxifen for the prevention of breast cancer: late results of the Italian Randomized Tamoxifen Prevention Trial among women with hysterectomy

Selective potentiation of paclitaxel (taxol)-induced cell death by mitogen-activated protein kinase kinase inhibition in human cancer cell lines

NSC23925, identified in a high-throughput cell-based screen, reverses multidrug resistance

A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry

Dose-dependent effects of stable cyclin B1 on progression through mitosis in human cells.

P304

1794-1801

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/15384047.2015.1095409

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-11-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

283492616

http://www.w3.org/2001/XMLSchema#string

P698

26529585

http://www.w3.org/2001/XMLSchema#string

P932

4847829

http://www.w3.org/2001/XMLSchema#string